CD109

From Wikipedia, the free encyclopedia
Jump to: navigation, search
CD109 molecule
Identifiers
Symbols CD109 ; CPAMD7; RP11-525G3.1
External IDs OMIM608859 MGI2445221 HomoloGene25183 GeneCards: CD109 Gene
RNA expression pattern
PBB GE CD109 gnf1h04600 at tn.png
PBB GE CD109 gnf1h06370 at tn.png
PBB GE CD109 gnf1h07791 at tn.png
More reference expression data
Orthologs
Species Human Mouse
Entrez 135228 235505
Ensembl ENSG00000156535 ENSMUSG00000046186
UniProt Q6YHK3 Q8R422
RefSeq (mRNA) NM_001159587 NM_153098
RefSeq (protein) NP_001153059 NP_694738
Location (UCSC) Chr 6:
74.41 – 74.54 Mb
Chr 9:
78.62 – 78.72 Mb
PubMed search [1] [2]

CD109 (Cluster of Differentiation 109) is a human gene.[1]

CD109 is a GPI-linked cell surface antigen expressed by CD34+ acute myeloid leukemia cell lines, T-cell lines, activated T lymphoblasts, endothelial cells, and activated platelets (Lin et al., 2002). In addition, the platelet-specific Gov antigen system, implicated in refractoriness to platelet transfusion, neonatal alloimmune thrombocytopenia, and posttransfusion purpura, is carried by CD109 (Kelton et al., 1990; Lin et al., 2002).[supplied by OMIM][1]

See also[edit]

References[edit]

Further reading[edit]

External links[edit]